Investing Profile

R. Jacob Vogelstein

InvestorVCFounder
Co-Founder and Managing Partner at Catalio Capital Management
Photo of R. Jacob Vogelstein, Managing Partner at Catalio Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Catalio Capital Managing Partner
$100K - $5.0M
$1.5M
10
CompanyStageDateRound SizeTotal Raised
Iambic
Series UnknownNov 2025$100M
Series BOct 2023$100M
Series AJul 2021$53M
$300M
Co-investors: Brian Keil (Alumni Ventures ), Naren Gupta (Nexus Venture Partners), Kurt von Emster (Abingworth), Ayman AlAbdallah
Syndeio Biosciences
Series UnknownMay 2025$90M
$90M
Clasp Therapeutics
Series AMar 2024$150M
$150M
Co-investors: George C. Petrocheilos (Catalio Capital), Andrea van Elsas (Third Rock Ventures), Jack Nielsen (Vivo Capital)
NextPoint Therapeutics
Series BFeb 2024$43M
$43M
Haystack Oncology
Series ANov 2022$56M
$56M
Co-investors: George C. Petrocheilos (Catalio Capital)
Pheast Therapeutics
Series AApr 2022$76M
$76M
Co-investors: Steven Gillis (ARCH Venture Partners), George C. Petrocheilos (Catalio Capital)
Bayesian Health
Series UnknownJul 2021$15M
$15M
Co-investors: Vineeta Agarwala (Andreessen Horowitz), Julie Yoo (Andreessen Horowitz)
eNeura Therapeutics
Series DFeb 2018$17M
$17M